Pro-Dex, Inc.
Pro-Dex, Inc. (PDEX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pdex · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Pro-Dex, Inc. (PDEX) measures how much investors pay for each dollar of the company's trailing earnings. PDEX's current PE ratio of 17.34x is calculated by dividing its stock price of $65.00 by its TTM earnings per share of $3.75. −7.6% discount vs 5Y avg 18.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 14 fiscal years · Front-end computedMinQ1 · 25%16.8x
MedianQ3 · 75%32.6x
Max
At 17.34x, PDEX's current P/E is within its average historical range over the past 14 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pro-Dex, Inc.You PDEX | $208M | 17.34x | — | $3.75 |
 Apyx Medical Corporation APYX | $200M | N/A | — | -$0.27 |
 Cognition Therapeutics, Inc. CGTX | $89M | N/A | — | -$0.32 |
 Greenwich LifeSciences, Inc. GLSI | $318M | N/A | — | -$1.43 |
 Incannex Healthcare Limited IXHL | $39M | N/A | — | -$40.82 |
 Lucid Diagnostics Inc. LUCD | $98M | N/A | — | -$0.57 |
 Microbot Medical Inc. MBOT | $83M | N/A | — | -$0.29 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | 15.98x | $2.73 | -47.1% | |
2024-06-30 FY2024 | 30.18x | $0.61 | +213.1% | |
2023-06-30 FY2023 | 9.64x | $1.98 | -24.0% | |
2022-06-30 FY2022 | 12.68x | $1.26 | -50.0% | |
2021-06-30 FY2021 | 25.38x | $1.20 | +122.5% | |
2020-06-30 FY2020 | 11.40x | $1.56 | -15.1% | |
2019-06-30 FY2019 | 13.43x | $0.99 | -23.9% | |
2018-06-30 FY2018 | 17.66x | $0.38 | +261.3% | |
2017-06-30 FY2017 | 4.89x | $1.26 | -82.6% | |
2016-06-30 FY2016 | 28.01x | $0.20 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pro-Dex, Inc. (PDEX) measures how much investors pay for each dollar of the company's trailing earnings. PDEX's current PE ratio of 17.34x is calculated by dividing its stock price of $65.00 by its TTM earnings per share of $3.75.
Frequently asked questions
PDEX pe ratio · 6 questionsPDEX's current PE ratio is 17.34x as of 2026-06-09, based on a stock price of $65.00 and TTM EPS of $3.75. Data sourced from Financial Modeling Prep via PDEX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pro-Dex, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09